CIITA and B-cell chronic lymphocytic leukemia: To test whether CIITA-dependent downregulation of MHC class II genes was prognostically important also for CLL, we analyzed whether CIITA-RNA levels predicted the time to first treatment in a cohort of 266 treatment naive patients from the International Cancer Genome Consortium (ICGC)5,42.